We’re delighted to announce the publication of our preprint titled Benchmarking open access publication rates for the pharmaceutical industry and research-intensive academic institutions.
This study analyses open access (OA) publication trends for biomedical and health sciences research using data from our open access dashboard.
The dashboard – which was launched in 2023 – is an online tool that uses data from the Lens platform to benchmark OA rates for articles with pharma- and university-affiliated authors. It allows live monitoring of the percentage of journal articles published OA and tracks how OA publication patterns change over time.
The study reveals that pharma companies have a slightly higher proportion of OA publications, with 76.6% of their research articles available OA compared with 69.5% of those from academic institutions. Other key findings are as follows.
- The most common OA models are gold and hybrid.
- Oncology research has lower OA rates than other therapy areas.
- The growth rate of OA publications is faster for pharma companies than for academic institutions.
Don’t have time to read the whole preprint? Why not listen to it?!
To celebrate International Open Access Week, we’ve transformed the preprint into a song. “We developed the song to encourage authors to get creative in their communication,” says Tomas Rees (Director of Innovation at Oxford PharmaGenesis). “We thought it would be fun to make a ‘plain language summary’ of the preprint in song format. Both the lyrics and the song itself are generated by AI [artificial intelligence]. The purpose of the song is to lay out the take-home messages from the manuscript in a format that encourages sharing and makes people curious to check the paper and the dashboard.”
You can listen to the ‘plain language song’ on our YouTube channel. We welcome your feedback on this innovation via our social media channels.
References
- Rees T, Philippon V, Liew A et al. Benchmarking open access publication rates for the pharmaceutical industry and research-intensive academic institutions. bioRxiv 2024.09.14.613042 [Preprint]. 2024. Available from: https://doi.org/10.1101/2024.09.14.613042 (Accessed 14 October 2024).
Are you committed to open access? Make your commitment public by endorsing the open Pharma position statement.
